ISR — ISR Immune System Regulation Holding AB (publ) Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for ISR Immune System Regulation Holding AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | — |
| Cost of Revenue | |||||
| Gross Profit | 0 | — | — | — | — |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 20.9 | 28.9 | 29.9 | 78.6 | 206 |
| Operating Profit | -20.9 | -28.9 | -29.9 | -78.6 | -206 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -21 | -29.1 | -31.1 | -78.6 | -213 |
| Net Income After Taxes | -21 | -29.1 | -31.1 | -78.6 | -213 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -21 | -29.1 | -31.1 | -78.6 | -213 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -21 | -29.1 | -31.1 | -78.6 | -213 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.766 | -1.06 | -0.585 | -1.14 | -3.09 |
| Dividends per Share |